Analytical Data
-
基因名
PCDHb16
- Application
-
别名
PCDHB8a; PCDH3X; PCDH-BETA16; ME1; Cadherin ME1; Protocadherin-3x; PCDHbeta 16
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NRJ7
-
表达区间
Val35~Val347
-
分子量
39kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PCDHb16, a member of the protocadherin family, has garnered interest in recent years due to its potential roles in neural development and cell signaling. Protocadherins are known to be crucial for mediating cellular interactions and establishing specific neuronal connections in the brain. PCDHb16, in particular, is implicated in the modulation of synaptic functions and may play a key role in processes related to cell adhesion, neurite outgrowth, and the formation of neuronal networks. Investigating the recombinant protein of PCDHb16 is vital for understanding its structural and functional properties, which can shed light on its involvement in synaptic plasticity and neurodevelopmental disorders. The study of PCDHb16 may also provide insights into the mechanisms underlying various neurological conditions, as perturbations in protocadherin expression or function have been associated with developmental disruptions and psychiatric disorders. Furthermore, characterizing PCDHb16 as a recombinant protein allows for controlled experiments to elucidate its biological activities and interactions with other proteins. This understanding could lead to potential therapeutic strategies targeting PCDHb16-related pathways in the treatment of neurodevelopmental and neurodegenerative diseases, emphasizing the significance of this research in both basic neuroscience and clinical applications.












